Efficacy and Safety of Short-Term Intensive Statin Therapy in Patients with Acute Coronary Syndrome

孙丽娜,王宁夫,李虹,潘浩,康兰,许轶洲,周亮,高微,朱钢杰,谢剑昶

DOI: https://doi.org/10.3760/cma.j.issn.1671-7368.2014.05.012

2014-01-01

BMJ

Abstract:Objective To evaluate the efficacy and safety of short- term high doses of atorvastatin intensive treatment for patients with acute coronary syndrome (ACS) during hospitalization. Methods A total of 355 ACS patients who were treated in our hospital were enrol ed into this study. Among them 180 cases received atorvastatin 80mg at admission and atorvastatin 80mg/night during the hospitalization (intensive group), and other 175 cases received atorvastatin 20mg/night) from admission (convention group). The serum levels ALT, AST, Cr, TG, TC, HDL- C, LDL- C, creatine kinase (CK) and creatine kinase isoenzyme (CK- MB) at admission and 1 week after admission were measured in both groups. Results The TC, TG and LDL- C levels were significantly lower and HDL- C levels were significantly higher at 1 week after treatment than those at baseline levels in both groups (al P<0.01);while The TG levels in intensive group were significantly higher than those in conventional group 1 week after treatment (P<0.05). The ALT, AST, Cr, CK and CK- MB levels were improved significantly in both groups 1 week after treatment (P<0.01);while compared with the conventional group, the ALT and AST levels in intensive group were markedly increased (P<0.01). Conclusion The short- term intensive statin therapy is as safe as the conventional treatment, but is more effective for pa-tients with acute coronary syndrome.